China Pharma Holdings (CPHI) Capital Expenditures Growth (5y) (2015 - 2025)
China Pharma Holdings (CPHI) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | China Pharma Holdings | 18.56 Mn | 18.39 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.89% |
| Sep 30, 2025 | -70.19% |
| Jun 30, 2025 | -14.87% |
| Mar 31, 2025 | -30.03% |
| Dec 31, 2024 | -17.21% |
| Sep 30, 2024 | -22.47% |
| Dec 31, 2023 | -23.96% |
| Sep 30, 2023 | 82.30% |
| Jun 30, 2023 | -16.77% |
| Mar 31, 2023 | -77.12% |
| Dec 31, 2022 | -19.08% |
| Sep 30, 2022 | 74.71% |
| Jun 30, 2022 | 47.41% |
| Mar 31, 2022 | -44.59% |
| Dec 31, 2021 | -41.95% |
| Sep 30, 2021 | 83.24% |
| Dec 31, 2020 | 25.23% |
| Sep 30, 2020 | 41.72% |
| Jun 30, 2020 | 17.74% |
| Mar 31, 2020 | 49.16% |